Table 2.
Primary research with healthcare providers/payers/HTA bodies/regulatory authorities; Stakeholders’ profiles.
| Country | Perspective | Education | Organisation(s) |
|---|---|---|---|
| Austria | HTA body’s representative | Communications & psychology, PhD in social medicine | HTA body: Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA), Vienna (academic non-profit institute, independent entity for scientific decision-making support in the health sector) |
| Belgium | Health insurer | PharmD | National Health Insurance: National Institute for Health and Disability Insurance (NIHDI RIZIV/INAMI) |
| France | Hospital pharmacist | PharmD | Public teaching hospital in Paris/hospital pharmacy |
| France | Physician | MD, PhD Specialty: psychiatry | Public teaching hospital in Marseille |
| France | HTA body representative (Ex)/physician | MD, general practitioner | Transparency Committee (French HTA, committee within French Health Authority, HAS) Private practice as GP |
| France/ Europe |
HTA body’s representative/regulatory authority’s representative/physician | MD Specialty: dermatology/ endocrinology |
Haute Autorité de Santé (HAS) European Network for Health Technology Assessment (EUnetHTA) French Medicines Agency (AFSSAPS/ANSM) European Medicines Agency EMA) |
| France/ Europe |
Regulator (Ex)/physician | MD Specialty: cardiology/ diabetology (hospital) |
European Medicines Agency (EMA/CHMP) Teaching hospital in Paris |
| Germany | Health insurer/proxy payer | MD (epidemiologist) | Public Physicians Association (Association of Physicians of Hessen) G-BA (Federal Joint Committee) advisor |
| Germany | Proxy payer (expert/advisor) | Health economist, PhD in public health | German Social Health Insurance |
| Italy | Physician | MD Specialty: neurologist | Public hospital in Cesena |
| Italy | HTA body’s representative/hospital pharmacist | PharmD | HTA body in Piedmont Region Public hospital in Turin |
| Italy | HTA body’s representative/hospital pharmacist | PharmD | HTA body in Sicily region Public hospital in Messina |
| Poland | Hospital pharmacist | PharmD | Public teaching hospital in Krakow |
| Poland | Physician | MD, PhD | Out-patient specialist care unit (commercial): ENEL-MED, Cracow, Poland; UNICARDIA, Cracow, Poland |
| Poland | Ex-HTA body’s representative | MD, PhD | HTA body: The Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw |
| Spain | HTA body’s advisor | Health economist | HTA regional bodies (incl. Catalonia, Basque Country, Andalusia, Galicia) |
| The Netherlands |
HTA body’s representative (ex/advisor) | Econometrics, health economist, PhD | HTA body: CVZ (now called ZIN (Zorginstituut Nederland)) |
| Sweden | HTA body representative (ex/decision-maker) | Health Economist, PhD | HTA body: Dental and Pharmaceutical Benefits Agency (TLV) |
| Sweden | Proxy payer/HTA body (academic) | Health economist, PhD | Public University, Department of Medical and Health Sciences, Division: Centre for Medical Technology Assessment, Linköping University |
| United Kingdom (Scotland) | HTA body’s advisor | Health economist | HTA body: Scottish Medicines Consortium |